27857690|t|Interferon-Beta Increases Plasma Ceramides of Specific Chain Length in Multiple Sclerosis Patients, Unlike Fingolimod or Natalizumab.
27857690|a|Fingolimod is used for the treatment of multiple sclerosis (MS) and targets receptors for the bioactive sphingolipid sphingosine-1-phosphate (S1P). Whether fingolimod or other MS therapies conversely affect plasma concentrations of sphingolipids has, however, not yet been analyzed. Herein, we quantified 15 representative sphingolipid species by mass spectrometry in plasma from relapsing-remitting MS patients currently under fingolimod (n = 24), natalizumab (n = 16), or IFN-beta (n = 18) treatment. Healthy controls (n = 21) and untreated MS patients (n = 11) served as control groups. IFN-ss treatment strongly increased plasma level of C16:0, C18:0, C20:0, and C24:1 ceramides compared to healthy controls, untreated patients, or patients receiving fingolimod or natalizumab medication. Natalizumab treatment increased plasma concentrations of both S1P and sphinganine-1-phosphate, whereas fingolimod treatment did not affect any of these lipids. Correlations of sphingolipids with the Expanded Disability Status Scale and other disease specific parameters revealed no systemic change of sphingolipids in MS, independent of the respective treatment regime. These results indicate type I interferon treatment to cause a strong and specific increase in ceramide level. If confirmed in larger cohorts, these data have implications for the efficacy and adverse effects of IFN-beta. Moreover, quantification of ceramides soon after therapy initiation may help to identify therapy-responsive patients.
27857690	0	15	Interferon-Beta	Gene	3456
27857690	33	42	Ceramides	Chemical	MESH:D002518
27857690	71	89	Multiple Sclerosis	Disease	MESH:D009103
27857690	90	98	Patients	Species	9606
27857690	107	117	Fingolimod	Chemical	MESH:D000068876
27857690	121	132	Natalizumab	Chemical	MESH:D000069442
27857690	134	144	Fingolimod	Chemical	MESH:D000068876
27857690	174	192	multiple sclerosis	Disease	MESH:D009103
27857690	194	196	MS	Disease	MESH:D009103
27857690	238	250	sphingolipid	Chemical	MESH:D013107
27857690	251	274	sphingosine-1-phosphate	Chemical	MESH:C060506
27857690	276	279	S1P	Chemical	MESH:C060506
27857690	290	300	fingolimod	Chemical	MESH:D000068876
27857690	310	312	MS	Disease	MESH:D009103
27857690	366	379	sphingolipids	Chemical	MESH:D013107
27857690	457	469	sphingolipid	Chemical	MESH:D013107
27857690	514	536	relapsing-remitting MS	Disease	MESH:D020529
27857690	537	545	patients	Species	9606
27857690	562	572	fingolimod	Chemical	MESH:D000068876
27857690	583	594	natalizumab	Chemical	MESH:D000069442
27857690	608	616	IFN-beta	Gene	3456
27857690	677	679	MS	Disease	MESH:D009103
27857690	680	688	patients	Species	9606
27857690	776	781	C16:0	Chemical	-
27857690	783	788	C18:0	Chemical	MESH:C031183
27857690	790	795	C20:0	Chemical	-
27857690	801	816	C24:1 ceramides	Chemical	-
27857690	857	865	patients	Species	9606
27857690	870	878	patients	Species	9606
27857690	889	899	fingolimod	Chemical	MESH:D000068876
27857690	903	914	natalizumab	Chemical	MESH:D000069442
27857690	927	938	Natalizumab	Chemical	MESH:D000069442
27857690	989	992	S1P	Chemical	MESH:C060506
27857690	997	1020	sphinganine-1-phosphate	Chemical	MESH:C060504
27857690	1030	1040	fingolimod	Chemical	MESH:D000068876
27857690	1079	1085	lipids	Chemical	MESH:D008055
27857690	1103	1116	sphingolipids	Chemical	MESH:D013107
27857690	1228	1241	sphingolipids	Chemical	MESH:D013107
27857690	1245	1247	MS	Disease	MESH:D009103
27857690	1391	1399	ceramide	Chemical	MESH:D002518
27857690	1508	1516	IFN-beta	Gene	3456
27857690	1546	1555	ceramides	Chemical	MESH:D002518
27857690	1626	1634	patients	Species	9606
27857690	Positive_Correlation	MESH:D002518	3456
27857690	Association	MESH:C060506	MESH:D009103
27857690	Association	MESH:C060506	MESH:D000068876
27857690	Association	MESH:D000068876	MESH:D013107
27857690	Positive_Correlation	MESH:C060506	MESH:D000069442
27857690	Association	MESH:D009103	3456
27857690	Positive_Correlation	MESH:C060504	MESH:D000069442
27857690	Negative_Correlation	MESH:D000069442	MESH:D020529
27857690	Negative_Correlation	MESH:D000068876	MESH:D009103
27857690	Negative_Correlation	MESH:D020529	3456
27857690	Negative_Correlation	MESH:D000068876	MESH:D020529
27857690	Comparison	MESH:D000068876	MESH:D000069442

